HeikkinenTEkbladUKeroPEkbladSLaineK. Citalopram in pregnancy and lactation. Clin Pharmacol Ther2002;72(2):184–91.
2.
NonacsRCohenLS. Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am2003;26(3):547–62.
3.
BonariLBennettHEinarsonAKorenG. Risks of untreated depression during pregnancy. Can Fam Physician2004;50:37–9.
4.
EinarsonAKorenG. New antidepressants in pregnancy. Can Fam Physician2004;50:227–9.
5.
MarcusSMBarryKLFlynnHATandonRGredenJF. Treatment guidelines for depression in pregnancy. Int J Gynaecol Obstet2001;72(1):61–70.
6.
HendrickVAltshulerL. Management of major depression during pregnancy. Am J Psychiatry2002;159(10):1667–73.
7.
WardRKZamorskiMA. Benefits and risks of psychiatric medications during pregnancy. Am Fam Physician2002;66(4):629–36.
8.
KallenB. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med2004;158(4):312–6.
9.
SimonGECunninghamMLDavisRL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry2002 Dec;159(12):2055–61.
10.
CasperRCFleisherBELee-AncajasJCGillesAGaylorEDeBattistaAFollow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr2003;142(4):402–8.
11.
KulinNAPastuszakASageSRSchick-BoschettoBSpiveyGFeldkampMPregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA1998;279(8):609–10.
12.
WisnerKLGelenbergAJLeonardHZarinDFrankE. Pharmacologic treatment of depression during pregnancy. JAMA1999;282(13):1264–9.
13.
HendrickVSmithLMSuriRHwangSHaynesDAltshulerL. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol2003;188(3):812–5.
14.
EinarsonAFatoyeBSarkarMLavigneSVBrochuJChambersCPregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry2001;158(10):1728–30.
15.
EinarsonABonariLVoyer-LavigneSAddisAMatsuiDJohnsonYA multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatry2003;48(2):106–10.
16.
NulmanIRovetJStewartDEWolpinJPace-AsciakPShuhaiberSChild development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry2002;159(11):1889–95.
Health Canada Online [homepage on the Internet]. Ottawa: Health Canada; 2004 [cited 2004 Aug 9]. Health Canada advises of potential adverse effects of SSRIs and other anti-depressants on newborns. Available: www.hc-sc.gc.ca/english/protection/warnings/2004/2004_44.htm (accessed August 10, 2004).
19.
HaleT. Medications and mother's milk. 10th ed.Amarillo: Pharmasoft Publishing; 2002.